NexCure partners with health systems to build and operate outpatient treatment centers focused on CAR-T and T-cell engager therapies. The company's platform integrates AI-powered patient selection, remote monitoring, and standardized clinical protocols to expand access to advanced cancer treatments beyond the roughly 150 US hospitals currently offering CAR-T. NexCure aims to bring these lifesaving therapies closer to patients' homes.
Funding
Funding not disclosed
Founders
Product
Problem
Only 150 of the 6,100 US hospitals (2%) administer CAR-T therapy, creating a severe capacity bottleneck that restricts patient access to lifesaving advanced cancer treatments. Specialized cancer centers with limited infrastructure and geographic concentration leave many patients unable to receive these therapies close to home.
Solution
NexCure partners with health systems to build and operate outpatient treatment centers dedicated to CAR-T and T-cell engager therapies. The company bridges the infrastructure gap by developing innovative centers that bring advanced therapeutics closer to patients' communities. NexCure's platform integrates AI-powered patient selection, remote monitoring, and standardized clinical protocols to ensure safe, compassionate, and personalized treatment delivery. By empowering health systems to scale delivery, NexCure improves outcomes and meets patients where they are, making outpatient CAR-T therapy an achievable reality.
Target Audience
Primary customers are health systems and hospitals seeking to expand their capacity for delivering CAR-T and other advanced cell therapies to patients in outpatient settings.
Features
- AI-powered patient selection to identify appropriate candidates for CAR-T and T-cell engager therapies
- Remote monitoring capabilities that enable continuous patient oversight outside traditional hospital settings
- Standardized clinical protocols designed to ensure consistent, high-quality care across multiple treatment centers
- Outpatient treatment center development and operations model that expands capacity beyond specialized cancer centers
- Partnership-based approach that enables health systems to scale advanced therapy delivery without building infrastructure from scratch